We found that conditioning of whole blood from patient with GBM with IL-2, IL-15 and IL-21 significantly improved the IFN-γ response to the mesothelin precursor peptide pool, as well as the MPF subcomponent (Figure 2A). This evidence concerns the gene IL21 and glioblastoma.